“Cardiac Magnetic Resonance Imaging In The Evaluation Of Patients With Valvular Heart Disease”, Journal of Pharmaceutical Negative Results, pp. 1349–1367, Jan. 2023, doi: 10.47750/pnr.2023.14.02.174.